Tapewire

Nasdaq · USD

SNOA

Sonoma Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
8177
SEC CIK
0001367083
Parsed reports
129

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 30, 2016 Filed Dec 2, 2016 22:29 UTC
Miller Robert EChief Financial Officer
GrantCommon Stock, $0.0001 par value per share 15,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-16-000849 · oculus_f4-miller.xml · nonDerivative · entry 1

Miller Robert E · CIK 0001367082 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,964

F1 · price: These shares were granted to Mr. Miller as bonus compensation, based on the closing price of the Corporation's common stock of $4.81 on November 30, 2016.

Read SEC document
November 29, 2016 Filed Nov 30, 2016 16:57 UTC GrantCommon Stock, $0.0001 par value per share 1,035 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-16-000813 · barbari_frm4.xml · nonDerivative · entry 1

BARBARI SHARON SURREY · CIK 0001240499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,244

F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.

Read SEC document
November 29, 2016 Filed Nov 30, 2016 22:02 UTC GrantCommon Stock, $0.0001 par value per share 1,423 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-16-000816 · mclaughlin_frm4.xml · nonDerivative · entry 1

MCLAUGHLIN JOHN · CIK 0001203240 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,999

F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.

Read SEC document
November 29, 2016 Filed Nov 30, 2016 22:02 UTC GrantCommon Stock, $0.0001 par value per share 1,229 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-16-000815 · harrison_frm4.xml · nonDerivative · entry 1

Harrison Russell Joseph · CIK 0001592423 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,917

F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.

Read SEC document
November 29, 2016 Filed Nov 30, 2016 21:58 UTC GrantCommon Stock, $0.0001 par value per share 841 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-16-000814 · birnbaum_frm4.xml · nonDerivative · entry 1

Birnbaum Jay E · CIK 0001397470 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,722

F1 · price: The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.